How Does Cannabis Use Impact Respiratory Health?

Smoking cannabis can irritate the airways and cause cough, mucus production, and bronchitis symptoms. Vaping also exposes the lungs to an aerosol and should not be assumed safe. Questions about long-term COPD and lung-cancer risk remain less settled, partly because tobacco use and different patterns of cannabis exposure complicate the research.

The effects of THC and CBD also need to be distinguished from the effects of inhaling smoke or aerosol. A possible biological effect of a cannabinoid does not establish that a cannabis product treats lung disease.

Smoking, Bronchitis, and Lung Cancer

Cannabis smoke contains many of the same irritants, toxins, and carcinogens as tobacco smoke. Regular smoking is associated with cough, phlegm, and bronchitis symptoms; these symptoms often improve after stopping. A bong does not make smoke harmless.

For lung cancer and COPD, the evidence is less conclusive than it is for tobacco. That uncertainty should not be interpreted as evidence that cannabis smoke cannot damage the lungs. Studies must account for tobacco exposure, how much cannabis people use, and enough follow-up time to detect disease. The CDC’s lung-health overview distinguishes the established symptom concerns from these unresolved long-term risks.

What Recent Research Adds About Asthma and COPD

A 2025 study of 379,049 adults found that daily inhaled cannabis use was associated with higher odds of reported asthma, including among people without a lifetime history of tobacco-cigarette use. The association with COPD was present in the overall sample but was not statistically significant in that tobacco-free subgroup.

This was a cross-sectional survey: it measured cannabis use and reported disease at the same time. It cannot establish whether cannabis caused the condition or which came first.

A different longitudinal SPIROMICS analysis followed middle-aged and older adults with tobacco-smoking histories for an average of about four years. It did not find faster COPD progression or a higher rate of new COPD among marijuana users. That finding does not establish safety over decades or apply automatically to people without tobacco exposure.

For someone who already has asthma or COPD, inhaled irritants remain an avoidable concern. Temporary airway-opening effects reported in older THC experiments are not evidence that smoking cannabis is an appropriate treatment. Continue prescribed inhalers and the treatment plan agreed with your clinician.

Vaping Is Not Proven Safe for the Lungs

Vaping cannabis avoids burning plant material, but the resulting aerosol depends on the device, temperature, and product ingredients. Avoiding combustion does not establish that long-term lung outcomes are safe.

A 2026 longitudinal study of 5,211 young adults examined new respiratory symptoms over approximately two years. Smoking cannabis alone and combining smoking with vaping were associated with higher odds of functionally important symptoms compared with neither method. Vaping alone was not significantly associated, but the estimate was imprecise and could not rule out harm. When researchers excluded people using tobacco products at baseline, only the combined smoking-and-vaping association remained statistically significant. These observational results are preliminary; they do not prove vaping is harmless or that switching methods prevents disease.

The 2019 EVALI outbreak also showed that certain vaping products can cause severe acute lung injury. CDC investigations linked the outbreak strongly to vitamin E acetate in THC vaping products, particularly products from informal sources. That history is distinct from estimating the chronic risk of every device or formulation.

Edibles, CBD, and Medical Cannabis

Edibles and swallowed oils avoid direct smoke or aerosol exposure. They still carry risks, including delayed intoxication, prolonged impairment, accidental overconsumption, and medication interactions. A non-inhaled product is not automatically an effective or appropriate treatment for someone with lung disease.

CBD should not be used as a remedy for smoke-related lung damage. Laboratory findings about inflammation do not establish clinical benefit for asthma, COPD, or injury from smoking. People considering a cannabinoid for another medical problem should discuss both the evidence for that condition and the safest appropriate treatment options.

Street products sold as Spice or K2 are another concern and should not be confused with regulated prescription cannabinoid medicines. Their contents and effects can be unpredictable; the word “synthetic” alone does not identify a product’s medical quality or safety.

When Extra Caution Is Needed

The American Thoracic Society advises against smoking cannabis, particularly for people with existing lung disease. Cannabis can contain mold, which presents additional concerns for people with weakened immune systems, including transplant recipients and people receiving chemotherapy. Keep smoke away from other people, especially children.

Tell your clinician whether you smoke, vape, or use oral products, how often you use them, and whether you also use tobacco. New or worsening cough, wheeze, or breathlessness warrants assessment rather than an assumption that it is a normal effect of cannabis. Severe breathing difficulty or significant chest pain requires urgent medical care.

For respiratory health, reducing exposure to inhaled irritants is more useful than relying on claims that THC opens the airways or CBD counteracts smoke. If stopping is difficult, ask for help with cannabis or tobacco dependence as part of your lung-health care.